Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression
出版年份 2017 全文链接
标题
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 30, Pages E6137-E6146
出版商
Proceedings of the National Academy of Sciences
发表日期
2017-07-11
DOI
10.1073/pnas.1700655114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA
- (2017) Stuart M. Fell et al. GENES & DEVELOPMENT
- A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
- (2016) Eli M. Wallace et al. CANCER RESEARCH
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth
- (2016) Michael S. Nakazawa et al. Nature Communications
- DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
- (2015) Olga Grishina et al. BMC CANCER
- DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
- (2015) Soledad Gómez et al. Epigenomics
- Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells
- (2015) Flora Cimmino et al. Scientific Reports
- Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome
- (2015) Oncotarget
- HIF2A and IGF2 Expression Correlates in Human Neuroblastoma Cells and Normal Immature Sympathetic Neuroblasts
- (2015) Sofie Mohlin et al. NEOPLASIA
- Decitabine Induces Delayed Reactive Oxygen Species (ROS) Accumulation in Leukemia Cells and Induces the Expression of ROS Generating Enzymes
- (2014) Tamer E. Fandy et al. CLINICAL CANCER RESEARCH
- Prognostic Potential of DNA Methylation and Transcript Levels of HIF1A and EPAS1 in Colorectal Cancer
- (2014) Agnieszka Anna Rawłuszko-Wieczorek et al. MOLECULAR CANCER RESEARCH
- Comprehensive analysis of DNA methylation data with RnBeads
- (2014) Yassen Assenov et al. NATURE METHODS
- The Correlation of Expression Levels of HIF-1 and HIF-2 in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome
- (2013) S.-L. Yang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinical application of the CpG island methylator phenotype to prognostic diagnosis in neuroblastomas
- (2013) Kiyoshi Asada et al. JOURNAL OF HUMAN GENETICS
- The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
- (2013) Yang Liao et al. NUCLEIC ACIDS RESEARCH
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
- (2013) H Kocak et al. Cell Death & Disease
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
- (2012) Andrew E. Teschendorff et al. BIOINFORMATICS
- Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
- (2012) Nimrod B Kiss et al. BMC Medical Genetics
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway
- (2012) Hai-Xiang Sun et al. HEPATOLOGY
- Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma
- (2012) D. K. Krishnadas et al. PEDIATRICS
- Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
- (2012) Anneleen Decock et al. GENOME BIOLOGY
- Integration of CNS survival and differentiation by HIF2α
- (2011) C-Y Ko et al. CELL DEATH AND DIFFERENTIATION
- Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1
- (2010) G. Qing et al. CANCER RESEARCH
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
- (2010) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
- (2010) Paolo Fardin et al. Molecular Cancer
- How does PKMζ maintain long-term memory?
- (2010) Todd C. Sacktor NATURE REVIEWS NEUROSCIENCE
- HIF-2 deletion promotes Kras-driven lung tumor development
- (2010) J. Mazumdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
- (2009) Chen-Xin Dai et al. BMC CANCER
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
- (2009) L. A.M. Gravendeel et al. CANCER RESEARCH
- HIF-1 and HIF-2 Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1 Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization
- (2009) R. Noguera et al. CLINICAL CANCER RESEARCH
- HIF2α cooperates with RAS to promote lung tumorigenesis in mice
- (2009) William Y. Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- HIF-2 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
- (2009) A. Pietras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data
- (2009) Daniel Ramsköld et al. PLoS Computational Biology
- HIF-1α and HIF-2α have divergent roles in colon cancer
- (2008) Takaaki Imamura et al. INTERNATIONAL JOURNAL OF CANCER
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation